RecruitingNot Applicable

Inari VISION Registry

Italy, Portugal, United Kingdom1,000 participantsStarted 2025-03-07

Plain-language summary

This registry is a global prospective, non-randomized, multicenter, observational, active post-market data collection of Inari Medical devices and products.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Willing and able to provide informed consent per institution and geographical requirements
✓. Has received treatment with an eligible Inari Medical device. NOTE: If patients are consented prior to their procedure and the procedure does not take place, the patient will be considered a screen failure.
✓. Currently within enrollment window relative to their procedure
✓. Age ≥ 18 years

Exclusion criteria

✕. Is or will be inaccessible for registry follow-up
✕. Meets exclusion criteria required by local requirements
✕. Current or planned participation in another drug or device study that, in the investigator's opinion, would interfere with participation in this registry
✕. Is pregnant or breastfeeding at the time of enrollment

What they're measuring

Incidence of device-related, procedure-related, or fatal Adverse Events

Timeframe: Up to 180 days

Trial details

NCT IDNCT06600542

SponsorInari Medical

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2029-12-31

Contact for this trial

Ida Nelson

46 707 723010 ida.nelson@inarimedical.com

View on ClinicalTrials.gov More Pulmonary Embolism trials